| RS1553523037 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS1553523093 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1553523138 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Seizure |
| RS1553523142 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553523204 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1553523425 |
UNC80
|
Health Risk |
Likely pathogenic |
Hypotonia, infantile |
| RS1553523630 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS1553523940 |
CUL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Pseudohypoaldosteronism type 2E |
| RS1553524697 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553524807 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Dilated cardiomyopathy 1G |
| RS1553524865 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Severe myoclonic epilepsy in infancy |
| RS1553524889 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Severe myoclonic epilepsy in infancy |
| RS1553524977 |
SCN1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553525023 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553525036 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553525062 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553525146 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553525210 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553525267 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553525313 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1553525325 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553525337 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1553525358 |
SCN1A
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 2 |
| RS1553525592 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553525671 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1553525756 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553525857 |
PIKFYVE
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1553526002 |
ABCA12
|
Health Risk |
Pathogenic |
— |
| RS1553526116 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553526134 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1553526162 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, See cases |
| RS1553526228 |
SMARCAL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1553526619 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553526733 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
— |
| RS1553526884 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553527439 |
UNC80
|
Health Risk |
Pathogenic |
— |
| RS1553527930 |
SCN3A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS1553528016 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553529426 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553529427 |
BBS5
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 5, Bardet-Biedl syndrome 5 |
| RS1553529461 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553529527 |
SCN1A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Early-infantile DEE |
| RS1553530144 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553531134 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Severe myoclonic epilepsy in infancy |
| RS1553531178 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553531217 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553531385 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS1553531410 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553531682 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553531703 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1553532356 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553532470 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553532582 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553532671 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553532782 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553534041 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS1553534233 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553534296 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553534421 |
FASTKD1
|
Health Risk |
Pathogenic |
Glaucoma 1, open angle |
| RS1553535063 |
NDUFB3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553535161 |
SMARCAL1
|
Health Risk |
Likely pathogenic |
Schimke immuno-osseous dysplasia, Schimke immuno-osseous dysplasia |
| RS1553535216 |
NRXN1
|
Health Risk |
Likely pathogenic |
— |
| RS1553535457 |
SCN3A
|
Health Risk |
Conflicting classifications of pathogenicity |
SCN3A-related disorder, Developmental and epileptic encephalopathy |
| RS1553535841 |
CUL3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant pseudohypoaldosteronism type 1, NEURODEVELOPMENTAL DISORDER WITHOUT AUTISM OR SEIZURES |
| RS1553535902 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS1553536007 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1553536267 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553536305 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553537027 |
OBSL1
|
Health Risk |
Pathogenic |
— |
| RS1553537132 |
SCN3A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 62 |
| RS1553537332 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Miyoshi muscular dystrophy 1 |
| RS1553537512 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1553538469 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1553538488 |
OBSL1
|
Health Risk |
Likely pathogenic |
3M syndrome 2, Short stature |
| RS1553538835 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553538888 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1553538917 |
SATB2
|
Health Risk |
Likely pathogenic |
7 conditions, 7 conditions |
| RS1553538919 |
SATB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Chromosome 2q32-q33 deletion syndrome, Chromosome 2q32-q33 deletion syndrome |
| RS1553539391 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1553539620 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553539686 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553539777 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1553539995 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary familial dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1553540207 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553540213 |
SCN1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1553540263 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1553540282 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553540294 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553540342 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Early-infantile DEE |
| RS1553540382 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553540389 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553540464 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553540503 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553540508 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS1553540620 |
IHH
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1553540975 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1553541028 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1553541066 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1553541172 |
SCN1A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Seizure |
| RS1553541193 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |